Stocktoria
NovoCure Ltd NVCR
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2015-10-01
Chart by TradingView
3/9
Piotroski F — financial health
-2.29
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $655.4M | $605.2M | $509.3M | $537.8M | $535.0M |
| Gross profit | $488.5M | $468.0M | $381.1M | $423.0M | $420.2M |
| Operating income | -$153.8M | -$170.5M | -$232.9M | -$89.5M | -$44.3M |
| Net income | -$136.2M | -$168.6M | -$207.0M | -$92.5M | -$58.4M |
| Operating cash flow | -$49.0M | -$26.4M | -$73.3M | $30.8M | $82.8M |
| Free cash flow | -$75.7M | -$69.2M | -$100.4M | $9.4M | $58.6M |
| Total assets | $804.3M | $1.2B | $1.1B | $1.2B | $1.1B |
| Total liabilities | $463.9M | $880.6M | $783.6M | $750.5M | $729.0M |
| Shareholders' equity | $340.5M | $360.2M | $362.5M | $441.2M | $410.5M |
| Ratios | |||||
| Gross margin | 74.5% | 77.3% | 74.8% | 78.6% | 78.5% |
| Operating margin | -23.5% | -28.2% | -45.7% | -16.6% | -8.3% |
| Net margin | -20.8% | -27.9% | -40.6% | -17.2% | -10.9% |
| FCF margin | -11.5% | -11.4% | -19.7% | 1.8% | 11.0% |
| Return on assets | -16.9% | -13.6% | -18.1% | -7.8% | -5.1% |
| Return on equity | -40.0% | -46.8% | -57.1% | -21.0% | -14.2% |
| Debt / equity | 0.57× | 0.27× | 1.57× | 1.28× | 1.37× |
| Current ratio | 2.90 | 1.46 | 5.78 | 7.00 | 7.53 |
| Revenue growth | 8.3% | 18.8% | -5.3% | 0.5% | 8.2% |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -2.29 (distress)
- Working capital / assets 0.527
- Retained earnings / assets -1.604
- EBIT / assets -0.191
- Equity / liabilities 0.734
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001645113 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.